MYDA Advisors’s P3 Health Partners PIII Stock Holding History

MYDA Advisors’s Portfolio PIII Stock Details PIII Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-20,000	Closed	-$216K	–	251
2026 Q2	$216K	Buy	+20,000	New	+$149K	0.03%	160

Other funds holding PIII

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

Trinity Financial Advisors Columbus, Ohio $388M AUM 14.57% 1-Year Est. Return

Jane Street New York $1.19T AUM 51.51% 1-Year Est. Return

Diversified Trust Memphis, Tennessee $4.69B AUM 22.36% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return

Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

HRT Financial New York $57.2B AUM 52.85% 1-Year Est. Return

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $463B AUM

MYDA Advisors's PIII Position: Q3 2026 in Review

MYDA Advisors sold out of P3 Health Partners (PIII) in Q3 2026, closing a stake of 20,000 shares — an estimated $216K sold.

MYDA Advisors first reported a position in PIII in Q2 2026 and held it in 1 quarter. The position peaked at $216K in Q2 2026. 17 funds tracked by Wall St. Rank hold PIII as of Q3 2026.

MYDA Advisors reported no remaining P3 Health Partners position as of Q3 2026 after selling out during the quarter.
MYDA Advisors sold 20,000 P3 Health Partners shares in Q3 2026, an estimated $216K.
MYDA Advisors first reported a position in P3 Health Partners in Q2 2026 and held it in 1 quarter.
MYDA Advisors's P3 Health Partners position peaked at $216K in Q2 2026.
17 funds tracked by Wall St. Rank held P3 Health Partners as of Q3 2026.

Based on MYDA Advisors's 13F filing for Q3 2026, filed 13 Nov 2026.